← Leaderboards
Kimberly K Leslie
University Of New Mexico
$10,616,588
Attributed
$11,537,210
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.5M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$22,497,866 · 11
By mechanism
P50$8,816,233 · 3
R01$7,406,301 · 2
P01$3,746,975 · 4
K12$2,276,000 · 1
P30$252,357 · 1
Top collaborators
- Doris Mangiaracina Benbrook6 shared
- David G Mutch6 shared
- Xiangbing Meng5 shared
- Jason Gertz1 shared
Most similar at University Of New Mexico
Same institution · by research overlap
- Cheryl L Willman$57,213,396
- Michael Parks Bogenschutz$29,464,838
- David S Schade$14,177,133
- Holly Barrett Waldron$22,751,877
- Kristi L Watterberg$12,297,963
Others in their field
Top investigators on “Future”
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gary D Acton · University Of California-Davis$320,373,312
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$274,284,003
- Chanza Baytop · Westat, Inc.$271,217,917
- Everette D Joseph · Howard University$246,289,043
Research focus
FutureWomanEndometrial CarcinomaClinical TrialsMalignant NeoplasmsMolecularResearch PersonnelResponseSpecimenTumorUniversitiesFundingBaseCollaborationsSuccessInnovationCellsDesignProteinsResistanceMutationPathway InteractionsProgramsCancer Type
Grant awards (49)
Advancing Hormone Therapy for Endometrial Cancer$2,801,881
P01 · FY2025 · CA · contact PI
Route 66 Endometrial Cancer SPORE$2,581,832
P50 · FY2025 · CA
Evaluating promising progestins through surgical window trials in women newly diagnosed with endometrial cancer$670,393
P01 · FY2025 · CA · contact PI
Biospecimen Core$157,084
P01 · FY2025 · CA · contact PI
Developmental Research Program$147,824
P50 · FY2025 · CA · contact PI
Administrative Core$117,617
P01 · FY2025 · CA · contact PI
Route 66 Endometrial Cancer SPORE$2,248,055
P50 · FY2024 · CA
Route 66 Endometrial Cancer SPORE$749,771
P50 · FY2024 · CA
Admin-Core-001$194,375
P50 · FY2024 · CA
Route 66 Endometrial Cancer SPORE$194,375
P50 · FY2024 · CA
Developmental Research Program$154,872
P50 · FY2024 · CA · contact PI
Route 66 Endometrial Cancer SPORE$2,384,742
P50 · FY2023 · CA
Targeted Therapy for Endometrial Cancer$287,850
R01 · FY2023 · CA · contact PI
Developmental Research Program$160,387
P50 · FY2023 · CA · contact PI
Targeted Therapy for Endometrial Cancer$279,805
R01 · FY2022 · CA · contact PI
Targeted Therapy for Endometrial Cancer$178,025
R01 · FY2021 · CA · contact PI
Targeted Therapy for Endometrial Cancer$115,525
R01 · FY2021 · CA · contact PI
Targeted Therapy for Endometrial Cancer$293,550
R01 · FY2020 · CA · contact PI
Targeted Therapy for Endometrial Cancer$291,967
R01 · FY2019 · CA · contact PI
MTDH regulates Fanconi anemia repair pathway to mediate drug resistance$313,622
R01 · FY2018 · CA
MTDH regulates Fanconi anemia repair pathway to mediate drug resistance$313,622
R01 · FY2017 · CA
Targeted Therapy for Endometrial Cancer$252,448
R01 · FY2017 · CA · contact PI
MTDH regulates Fanconi anemia repair pathway to mediate drug resistance$313,622
R01 · FY2016 · CA
Targeted Therapy for Endometrial Cancer$252,448
R01 · FY2016 · CA · contact PI
MTDH regulates Fanconi anemia repair pathway to mediate drug resistance$314,231
R01 · FY2015 · CA
Targeted Therapy for Endometrial Cancer$252,448
R01 · FY2015 · CA · contact PI
MTDH regulates Fanconi anemia repair pathway to mediate drug resistance$326,981
R01 · FY2014 · CA
Targeted Therapy for Endometrial Cancer$244,874
R01 · FY2014 · CA · contact PI
The Iowa Women's Reproductive Health Research Career Development Center$375,200
K12 · FY2013 · HD · contact PI
Targeted Therapy for Endometrial Cancer$252,448
R01 · FY2013 · CA · contact PI
The Iowa Women's Reproductive Health Research Career Development Center$475,200
K12 · FY2012 · HD · contact PI
Targeted Therapy for Endometrial Cancer$287,761
R01 · FY2012 · CA · contact PI
The Iowa Women's Reproductive Health Research Career Development Center$475,200
K12 · FY2011 · HD · contact PI
Targeted Therapy for Endometrial Cancer$287,561
R01 · FY2011 · CA · contact PI
The Iowa Women's Reproductive Health Research Career Development Center$475,200
K12 · FY2010 · HD · contact PI
Targeted Therapy for Endometrial Cancer$296,254
R01 · FY2010 · CA · contact PI
The Iowa Women's Reproductive Health Research Career Development Center$475,200
K12 · FY2009 · HD · contact PI
Targeted Therapy for Endometrial Cancer$309,403
R01 · FY2009 · CA · contact PI
WOMEN'S CANCERS RESEARCH PROGRAM$58,698
P30 · FY2009 · CA · contact PI
Targeted Therapy for Endometrial Cancer$313,900
R01 · FY2008 · CA · contact PI
WOMEN'S CANCERS RESEARCH PROGRAM$57,518
P30 · FY2008 · CA · contact PI
WOMEN'S CANCERS RESEARCH PROGRAM$57,236
P30 · FY2007 · CA · contact PI
EGFR Blockade in Endometrial Cancer$321,561
R01 · FY2006 · CA · contact PI
WOMEN'S CANCERS RESEARCH PROGRAM$39,719
P30 · FY2006 · CA · contact PI
EGFR Blockade in Endometrial Cancer$319,955
R01 · FY2005 · CA
WOMEN'S CANCERS RESEARCH PROGRAM$39,186
P30 · FY2005 · CA
EGFR Blockade in Endometrial Cancer$320,845
R01 · FY2004 · CA
EGFR Blockade in Endometrial Cancer$331,845
R01 · FY2003 · CA
EGFR Blockade in Endometrial Cancer$333,750
R01 · FY2002 · CA